• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016 - 2022年美国医疗保险D部分受益人使用克霉唑倍他米松二丙酸酯(一种外用皮质类固醇 - 抗真菌复方产品)的处方情况

Prescribing of clotrimazole-betamethasone dipropionate, a topical combination corticosteroid-antifungal product, for Medicare part D beneficiaries, United States, 2016-2022.

作者信息

Currie Dustin W, Caplan Avrom S, Benedict Kaitlin, Hatfield Kelly M, Smith Dallas J, Lipner Shari R, Gold Jeremy A W

机构信息

Centers for Disease Control and Prevention, Atlanta, GA, USA.

The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA.

出版信息

Antimicrob Steward Healthc Epidemiol. 2024 Oct 17;4(1):e174. doi: 10.1017/ash.2024.435. eCollection 2024.

DOI:10.1017/ash.2024.435
PMID:39450091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11500261/
Abstract

During 2016-2022, Medicare part D beneficiaries filled 8,674,460 clotrimazole-betamethasone dipropionate prescriptions. Annual rates were stable (30.9 prescriptions/1,000 beneficiary-years in 2022, enough for one in every 33 beneficiaries). Diagnostic testing was infrequent, particularly among internal medicine, family medicine, and general practitioners, suggesting potential opportunities to improve diagnostic and prescribing practices.

摘要

在2016年至2022年期间,医疗保险D部分的受益人开具了8,674,460份克霉唑-倍他米松二丙酸酯处方。年开具率稳定(2022年为每1000受益人次30.9份处方,每33名受益人中就有一人足够使用)。诊断测试并不常见,尤其是在内科、家庭医学和全科医生中,这表明在改善诊断和处方实践方面存在潜在机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/363f/11500261/15df8c6681c9/S2732494X24004352_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/363f/11500261/15df8c6681c9/S2732494X24004352_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/363f/11500261/15df8c6681c9/S2732494X24004352_fig1.jpg

相似文献

1
Prescribing of clotrimazole-betamethasone dipropionate, a topical combination corticosteroid-antifungal product, for Medicare part D beneficiaries, United States, 2016-2022.2016 - 2022年美国医疗保险D部分受益人使用克霉唑倍他米松二丙酸酯(一种外用皮质类固醇 - 抗真菌复方产品)的处方情况
Antimicrob Steward Healthc Epidemiol. 2024 Oct 17;4(1):e174. doi: 10.1017/ash.2024.435. eCollection 2024.
2
Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.儿科医生开具高效皮质类固醇药物和克霉唑倍他米松二丙酸酯的处方情况。
Clin Ther. 1999 Oct;21(10):1725-31. doi: 10.1016/S0149-2918(99)80051-4.
3
------Topical Antifungal Prescribing for Medicare Part D Beneficiaries - United States, 2021.---- 2021 年美国医疗保险处方药计划(Medicare Part D)参保者局部用抗真菌药物处方情况。
MMWR Morb Mortal Wkly Rep. 2024 Jan 11;73(1):1-5. doi: 10.15585/mmwr.mm7301a1.
4
The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.持续不恰当地使用和过度使用复方克霉唑-倍他米松。
Dermatol Online J. 2021 Aug 15;27(8). doi: 10.5070/D327854686.
5
Clotrimazole-Betamethasone Dipropionate Prescribing for Nonfungal Skin Conditions.克霉唑-二丙酸倍他米松用于非真菌性皮肤病的处方开具
JAMA Netw Open. 2024 May 1;7(5):e2411721. doi: 10.1001/jamanetworkopen.2024.11721.
6
Use of clotrimazole/betamethasone diproprionate by family physicians.家庭医生使用克霉唑/二丙酸倍他米松。
Fam Med. 2000 Sep;32(8):561-5.
7
Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017.2013 年至 2017 年,医疗保险 D 部分受益人的普通科医生和肿瘤学家开具阿片类药物的处方模式变化。
JAMA Oncol. 2020 Aug 1;6(8):1271-1274. doi: 10.1001/jamaoncol.2020.2211.
8
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims.医疗保险中多名提供者开具阿片类药物处方的情况:保险索赔的回顾性观察性研究。
BMJ. 2014 Feb 19;348:g1393. doi: 10.1136/bmj.g1393.
9
Combination dermatological products: a comparison of betamethasone dipropionate/clotrimazole/gentamicin sulphate and flumethasone pivalate/clioquinol creams.复方皮肤科产品:丙酸倍他米松/克霉唑/硫酸庆大霉素与特戊酸氟米松/氯碘羟喹乳膏的比较
J Int Med Res. 1987 Sep-Oct;15(5):255-63. doi: 10.1177/030006058701500501.
10
Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.克霉唑/二丙酸倍他米松:常见皮肤真菌感染治疗的成本与并发症综述
Pediatr Dermatol. 2002 Jan-Feb;19(1):78-81. doi: 10.1046/j.1525-1470.2002.00027.x.

引用本文的文献

1
The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know.抗真菌耐药皮肤癣菌感染的兴起:皮肤科医生需要了解的内容。
Cutis. 2025 May;115(5):151-154. doi: 10.12788/cutis.1211.

本文引用的文献

1
Clotrimazole-Betamethasone Dipropionate Prescribing for Nonfungal Skin Conditions.克霉唑-二丙酸倍他米松用于非真菌性皮肤病的处方开具
JAMA Netw Open. 2024 May 1;7(5):e2411721. doi: 10.1001/jamanetworkopen.2024.11721.
2
------Topical Antifungal Prescribing for Medicare Part D Beneficiaries - United States, 2021.---- 2021 年美国医疗保险处方药计划(Medicare Part D)参保者局部用抗真菌药物处方情况。
MMWR Morb Mortal Wkly Rep. 2024 Jan 11;73(1):1-5. doi: 10.15585/mmwr.mm7301a1.
3
Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America.
北美地区特比萘芬耐药的皮肤癣菌和堇毛癣菌的存在。
J Clin Microbiol. 2023 Aug 23;61(8):e0056223. doi: 10.1128/jcm.00562-23. Epub 2023 Jul 11.
4
Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023.实地记录:美国首次报告由印多蒂毛癣菌引起的癣病例——纽约市,2021年12月至2023年3月
MMWR Morb Mortal Wkly Rep. 2023 May 12;72(19):536-537. doi: 10.15585/mmwr.mm7219a4.
5
The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.持续不恰当地使用和过度使用复方克霉唑-倍他米松。
Dermatol Online J. 2021 Aug 15;27(8). doi: 10.5070/D327854686.
6
The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses.甲真菌病和其他浅部真菌病中抗真菌耐药性日益严重的问题。
Am J Clin Dermatol. 2021 Mar;22(2):149-157. doi: 10.1007/s40257-020-00580-6. Epub 2020 Dec 22.
7
Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams.目前两种联合抗真菌/皮质类固醇乳膏的使用趋势。
J Pediatr. 2017 Jul;186:192-195.e1. doi: 10.1016/j.jpeds.2017.03.031. Epub 2017 Apr 21.
8
Cutaneous fungal infections are commonly misdiagnosed: A survey-based study.皮肤真菌感染常被误诊:一项基于调查的研究。
J Am Acad Dermatol. 2017 Mar;76(3):562-563. doi: 10.1016/j.jaad.2016.09.041. Epub 2016 Nov 17.
9
Diagnosis and management of tinea infections.癣感染的诊断与管理
Am Fam Physician. 2014 Nov 15;90(10):702-10.
10
Adverse effects of topical glucocorticosteroids.外用糖皮质激素的不良反应。
J Am Acad Dermatol. 2006 Jan;54(1):1-15; quiz 16-8. doi: 10.1016/j.jaad.2005.01.010.